At the Gulbenkian Institute of Molecular Medicine, scientific research has advanced based on lessons learned during the COVID-19 pandemic. In Miguel Castanho’s lab, researchers continue working on developing a drug with potential activity against multiple viruses, reinforcing the commitment to innovation and global health.
Learn more: https://www.rtp.pt/noticias/pais/ciencia-depois-da-covid-19-igmm-investiga-farmaco-contra-multiplos-virus_